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Sheila A. Stewart, PhD, associate
professor of cell biology and physiology
and of medicine, makes her way across
the Ellen S. Clark Hope Plaza into work
with son Konner, 6, and daughter Kyra,
2, in tow. While the kids watched
movies, Stewart met with laboratory
colleagues and an invited speaker. This
late February snowfall that shut down
schools was eclipsed just one month
later by a spring snowstorm that left a
record-breaking one-day snow total of
12.4 inches in St. Louis.
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Mapping a living relic
Ancient sea lamprey offers insight into origin of vertebrates

W

hat can we learn about human
evolution from an eel-like
creature with a sucker-shaped
mouth? Apparently, quite a lot.
A large team of scientists has decoded
the genome of a sea lamprey — one of the
few ancient, jawless species of vertebrates
that has survived through the modern era.
The findings were detailed Feb. 24 in
Nature Genetics.
Lampreys diverged from our own lineage about 500 million years ago, during
the Cambrian period. The new research
sheds light on how the species — long
considered an invasive predator — adapted
and thrived over the ages. Analyzing its
genome will provide scientists with insights
into the evolution of organisms as diverse
as frogs, chickens and humans, all of which
have backbones.
“The lamprey genome is unique in that
it has characteristics of vertebrates but it
2 Washington University School of Medicine

also carries evidence of earlier lineages,”
says study co-author Wesley C. Warren, PhD,
research associate professor of genetics at
the The Genome Institute at Washington
University. “Decoding this genome is providing us with unique insight into the origin
and evolution of all vertebrates.”
Based on fossil records, the Cambrian
period is noted as a time when living organisms exploded from single-celled structures
to complex, multicelled life forms. During
this era, many species developed jaws and
a skeletal frame that protected the brain,

Decoding the lamprey
genome is providing
scientists with unique
insight into the origin and
evolution of all vertebrates.

spine and nervous system. Some, in fact,
even developed brains that share some of
the same basic structures and functions as
the brains of modern humans.
For example, Warren and his colleagues
at the University of Kentucky and Michigan
State were surprised to discover genes in the
lamprey genome that direct the production
of myelin, the fatty sheath that insulates
nerve fibers and is needed for nerve signals
to move from the brain down the spinal cord
and into the extremities.
By mapping the sea lamprey genome,
scientists hope to uncover more details
about how and when humans evolved.
Future studies also could pinpoint when
people evolved jaws, arms and legs and an
adaptive immune system.
Understanding the sea lamprey’s genetic
makeup also may lead to ways to limit their
destruction of aquatic life. The invasive species feeds by attaching its sucker-shaped
mouth to the skin of other fish, including
salmon and trout, and burrowing its sharp
tongue and teeth into its prey. One sea lamprey can kill more than 40 pounds of fish in
its lifetime, and the U.S. and Canadian governments spend $10 million to $15 million
annually to control them in the Great Lakes.
Spring 2013

Pediatric brain injury program
saves lives, reduces disabilities
Children with traumatic brain injuries are more likely to
survive and avoid long-term disabilities when treated aggressively as part of a designated neurocritical care program that
brings together neurologists, neurosurgeons, trauma and
other critical care specialists, according to a new study at
Washington University School of Medicine.
The investigators tracked the results of such a program at
St. Louis Children’s Hospital. They studied the outcome of
123 cases before and after the hospital launched a pediatric
neurocritical care program (PNCP) in September 2005.
“We were amazed by the results,” says Jose A. Pineda, MD,
assistant professor of pediatrics and neurology, and director
of the program at St. Louis Children’s. “We analyzed the
data rigorously, and we found that our new program of care
resulted in a striking improvement in outcome for children
with severe traumatic brain injury. Mortality for these children was dramatically reduced, and we also noted a meaningful improvement in outcomes for survivors. We know
that children who suffer traumatic brain injuries have long
lives ahead and must reintegrate into society and be independent. That’s where we set the bar.”
The findings are available online in the journal The Lancet
Neurology. The study was led by Pineda, neurosurgeon
Jeffrey R. Leonard, MD, and
pediatric intensivist Allan Doctor,
The study is the first to
MD, chief of pediatric critical
show the benefits of a
care at St. Louis Children’s.
pediatric neurocritical care
The program’s aggressive
approach
to treating head injuries
program and an aggressive
suffered
in
car, bicycle, sportsapproach to treating brain
related and other such accidents
injuries in children.
targets secondary damage, especially damage provoked by dangerous increases in intracranial pressure.
Now that there is proof that PNCPs do make a significant
difference, Pineda and his fellow researchers have two key
goals: to sustain the outcomes they’ve seen since the program was created at St. Louis Children’s, and to spur other
institutions to implement their own such programs.
Pineda credits the success of the program in large part to
a close relationship with colleagues in neurosurgery, neurology, trauma surgery and radiology and other team members.
“We developed this collaborative, highly choreographed
clinical pathway after first forging a partnership in caring for
individual cases together,” says Pineda. “It’s incredibly
rewarding to see synergy emerge after bringing our teams
together to form the PNCP.”
outlook.wustl.edu
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Collaborative team improves outcomes

Student favorites Gregory M. Polites, MD, and Steven
C. Cheng, MD, share the spotlight at the annual Distinguished Service
Teaching Awards ceremony. Polites, associate professor of emergency
medicine, was presented with the Course Master of the Year Award by
the Class of 2015; Cheng, assistant professor of medicine, was given
the Professor of the Year Award by the Class of 2014. For a full list of
awardees at the event, please visit news.wustl.edu.

Rao receives prize for vision proposal
A Washington University retina specialist is one of 10 U.S.
scientists selected by the National Eye Institute (NEI), part
of the National Institutes of Health (NIH), for innovative
projects to improve or restore vision.
The winning proposal from Rajesh C. Rao, MD, a vitreoretinal surgery fellow in the Department of Ophthalmology
and Visual Sciences, was chosen from nearly 500 entries.
Rao was one of two retina clinicians
to receive the award and the youngest
winner in the national competition.
His proposal involves restoring
vision in patients whose retinas have
deteriorated from diseases like agerelated macular degeneration, the
leading cause of vision loss in adults.
Rao wants to reprogram skin and
blood cells from patients because they
can be easy to isolate and are compatible with the immune system. Once
reprogrammed, those cells could
be transplanted into the retina, the
structure at the back of the eye that
Rajesh C. Rao, MD
converts light into vision.
“We want to use gene therapy and other techniques to
repair the damage that occurs in degenerative retinal diseases,” says Rao. “By identifying the small molecules that
directly convert a mature cell into a retinal cell, we hope to
reprogram cells that already exist in the body to make them
useful in preserving or restoring vision.”
Outlook 3
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Human Connectome Project
releases brain connectivity data

Caregivers unite Brittany Perez, a graduating student
in the Program in Occupational Therapy, explains the proper way to
move a patient who has a Foley catheter in place. At a recent interdisciplinary learning event, Washington University occupational
therapy students and nursing students from the Goldfarb School of
Nursing at Barnes-Jewish College shared their knowledge. The two
groups practiced the proper use of hospital equipment and skills —
including patient transfers — vital to caring for patients.

Siteman south county location open
Physicians from the Alvin J. Siteman Cancer Center at
Barnes-Jewish Hospital and Washington University School of
Medicine began seeing patients in January at Siteman’s newest
outpatient location in south St. Louis County.
Located at Interstate 55 and Butler Hill Road, Siteman
Cancer Center–South County offers access to the same
advanced treatments and technology available at Siteman’s
main location at Washington University Medical Center.
“Treatment at a top 10 U.S. cancer center just got easier
for hundreds of thousands of area residents,” says Timothy J.
Eberlein, MD, Siteman’s director.
“Along with convenience,
World-class cancer care
patients at the new location will
at a top 10 U.S. cancer
benefit from the world-class cancer
center “just got easier”
care and outstanding research of our
Washington University physicians.”
for hundreds of thousands
Multidisciplinary care provided
of St. Louis area residents.
by radiation oncologists, medical
oncologists and surgeons will allow
patients to see as many as three physicians in one trip. This
team approach also means a patient’s treatment plan can be
determined in one visit.
Bruce J. Roth, MD, professor of medicine, is director of
medical oncology at the new location, and Parag J. Parikh,
MD, assistant professor of radiation oncology, is director of
radiation oncology.
Siteman’s two other satellite locations are in Creve Coeur
at Barnes-Jewish West County Hospital and in St. Charles
County at Barnes-Jewish St. Peters Hospital. Appointments
Enjoy interactive elements and added content
for any of the sites may be made by calling 314-747-7222 or
toll-free 800-600-3606 from 8 am to 4:30 pm CDT weekdays.
4 Washington University School of Medicine

The Human Connectome Project, a five-year endeavor to
link brain connectivity to human behavior, has released a set
of high-quality imaging and behavioral data to the scientific
community. The project has two major goals: to collect vast
amounts of data using advanced brain imaging methods on
a large population of healthy adults, and to make the data
freely available so that scientists worldwide can make further
discoveries about brain circuitry.
The initial data release includes brain imaging scans plus
behavioral information — individual differences in personality, cognitive capabilities, emotional characteristics and
perceptual function — obtained from 68 healthy adult volunteers. Over the next several years, the number of subjects
studied will increase steadily to a final target of 1,200. The
initial release is an important milestone because the new
data have much higher resolution in space and time than
data obtained by conventional brain scans.
The Human Connectome Project (HCP) consortium is led
by David C. Van Essen, PhD, Alumni Endowed Professor,
and Kamil Ugurbil, PhD, Director of the Center for Magnetic
Resonance Research and the McKnight Presidential Endowed
Chair Professor at the University of Minnesota.
“By making this unique
data set available now, and
continuing with regular
data releases every quarter,
the Human Connectome
Project is enabling the
scientific community to
immediately begin exploring relationships between
brain circuits and individual behavior,” says Van
Essen. “The HCP will have a
major impact on our underhumanconnectome.org
standing of the healthy
adult human brain, and it
will set the stage for future projects that examine changes in
brain circuits underlying the wide variety of brain disorders
afflicting humankind.”
The consortium includes more than 100 investigators
and technical staff at 10 institutions in the United States
and Europe. It is funded by 16 components of the National
Institutes of Health via the Blueprint for Neuroscience
Research (neuroscienceblueprint.nih.gov).
The imaging data set released by the HCP takes up about
two terabytes (2 trillion bytes) of computer memory.
Spring 2013
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JENNIFER HUNTER

WUSM co-leads international consortium

New digs

The planned facility, located at the corner of
Clayton and Newstead avenues, will replace the
50-year-old Shriners Hospital in Frontenac.
Inset: Shriner Ambassador Freddie J. Hanewinkel
holds the cast he wore as a baby during treatment
at Shriners Hospital for Children.

ROBERT BOSTON

Patients of Shriners Hospital
for Children and representatives from Shriners
and Washington University Medical Center
(including medical school Dean Larry J. Shapiro,
MD, sixth from right) broke ground March 20 on a
$50 million hospital on the medical center campus.
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effects of chemotherapy.
“Our results offer hope for targeting
these niches to treat specific cancers or
to improve the success of stem cell transplants,” says senior author Daniel C. Link,
MD, the Alan A. and Edith L. Wolff Professor
of Medicine. “Already, we and others are
leading clinical trials to evaluate whether it
is possible to disrupt these niches in patients
with leukemia or multiple myeloma.”
In a phase II pilot study led by medical
oncologist Geoffrey L. Uy, MD, assistant
professor of medicine, Link is evaluating
whether the drug G-CSF can alter the stem
cell niche in patients with acute lymphoblastic leukemia whose cancer has recurred
or is resistant to treatment.
While it’s too early to know whether
the treatment approach will be successful,
Link’s new research in mice is bolstered by
a companion paper in the same issue of
Nature. In that research, Sean J. Morrison,
PhD, director of the Children’s Medical
Center Research Institute at the University
of Texas Southwestern Medical Center in

Distinct niches exist in bone marrow to nurture different
types of blood stem cells. In mice bone marrow, blood
stem cells, highlighted in blue, are nurtured by support
cells shown in red and yellow.
Dallas, used similar molecular methods to
also discover distinct niches in the bone
marrow for blood stem cells.
“There’s a lot of interest right now in
trying to understand these niches,” Link
adds. “Both of these studies add new
information that will be important as we
move forward.”
Outlook 5
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n research that could one day improve
the success of stem cell transplants and
chemotherapy, scientists have found
that distinct niches exist in bone marrow to
nurture different types of blood stem cells.
Stem cells in the blood are the precursors to infection-fighting white blood cells
and oxygen-carrying red blood cells.
The research, by a team at the School
of Medicine, was reported Feb. 24 in the
advance online edition of Nature.
The new findings, in mice, suggest that
it may be possible to therapeutically target
support cells in a particular niche.
On the one hand, a drug that nourishes support cells could encourage blood
stem cells to establish themselves in the
bone marrow, enabling patients who have
had stem cell transplants to more quickly
rebuild their immune systems.
On the other, tumor cells are known to
hide in the bone marrow, and a drug that
disrupts the niche environment may drive
cancer cells into the bloodstream, where
they are more vulnerable to the damaging

DANIEL C. LINK, MD

Targeting stem cells to build immunity

pulse
Four medical school faculty
honored as AAAS fellows
ROBERT BOSTON

Distinguished efforts advance science
Photo ops

Vivian Elgin, shown here with the photo and
poster she created as part of Photovoice, a project in which participants document the people, places and things that make up their
daily lives. Supported by the National Institutes of Health (NIH), the
project is meant to serve as a conversation starter about the importance of cancer screening. Elgin’s work was part of a recent exhibition hosted by the Alvin J. Siteman Cancer Center’s Program for the
Elimination of Cancer Disparities.

Mecham serves as interim head
Robert P. Mecham, PhD, has been named interim head of the
Department of Cell Biology and Physiology.
Mecham, the Alumni-Endowed Professor of Cell Biology
and Physiology, replaces Helen Piwnica-Worms, PhD,
the Gerty T. Cori Professor, who has been named vice
provost, science, at the University of Texas MD Anderson
Cancer Center.
“Bob won the School of
Medicine’s distinguished Carl and
Gerty Cori Faculty Achievement
Award last year for his pioneering
research into the structures that join
cells into tissues and organs,” says
Larry J. Shapiro, MD, executive vice
chancellor for medical affairs and
dean of the School of Medicine. “He
has been a valued member of the
faculty since 1977, and I have every
confidence in his ability to lead the
Robert P. Mecham, PhD
department through this transition.”
Mecham focuses most of his research on the extracellular matrix, or the structures between cells that join them
together to form tissues and organs.
He was vice chairman of the Executive Committee of the
Faculty Council from 2002–03 and served as chairperson of
the Curriculum Evaluation Committee. He also is a member
of several university-wide committees.
A three-time winner of the university’s Distinguished
Teacher Award, Mecham has been extensively involved in
medical and graduate school instruction. In 2012, he received
the Carl and Gerty Cori Faculty Achievement Award.
6 Washington University School of Medicine

Four School of Medicine faculty members have been named
fellows of the American Association for the Advancement of
Science (AAAS), the world’s largest general scientific society.
The newest fellows are Alison Goate, PhD, Jeanne M.
Nerbonne, PhD, D.C. Rao, PhD, and Barry Sleckman, MD,
PhD. Members are given the rank of fellow, the highest
honor awarded by AAAS, by their peers in recognition of
scientifically or socially distinguished efforts to advance
science or its applications.
Goate, the Samuel and Mae S. Ludwig Professor of
Genetics in Psychiatry and director of the Hope Center
for Neurological Disorders at the School of Medicine, was
praised by colleagues for her work in the genetics of neuropsychiatric disease, particularly Alzheimer’s disease. She
also studies genetic risk for
substance dependence.
Nerbonne, the Alumni
Endowed Professor of
Molecular Biology and
Pharmacology, was lauded
by colleagues for her contributions to research and
training in the molecular
and cell biology of ion
channels that control
excitability in the cardiovascular and nervous
systems. Nerbonne also
leads the Translational
Cardiovascular Biobank and Repository (TCBR), funded in
part by the Children’s Discovery Institute and Washington
University’s Institute of Clinical and Translational Sciences
(ICTS), a resource for investigators interested in studying
heart and vascular conditions in adults and children.
Rao, director of the Division of Biostatistics, was honored
by colleagues for his contributions in the area of genetic
epidemiology and human genetics, and for his work in training the next generation of statisticians and epidemiologists.
Sleckman, the Conan Professor of Pathology and
Immunology, was lauded by peers for his work in the field
of immunology and biochemistry, particularly for his
pioneering research into how cells repair breaks in their
DNA and how problems in these repair processes can
contribute to cancer.
These School of Medicine faculty members were among
702 new fellows acknowledged in the Nov. 30 issue of
Science magazine.
Spring 2013
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Shining a light
Do tanning facilities communicate the risks to preteens?

A

survey of tanning salon operators
more likely to develop more common
in Missouri shows that 65 percent
nonmelanoma skin cancers, such as basal
would allow children as young
cell and squamous cell cancers.
as 10 to 12 years old to use tanning beds.
Of the states that regulate tanning bed
That’s despite evidence that any tanning
use, some ban minors until they reach a
bed use increases the risk of all skin cancers,
certain age; others require parental permisincluding melanoma, the deadliest form of
sion. Last year, California became the first
skin cancer, later in life.
state to prohibit the use of indoor tanning
The survey, part of a study led by
beds by anyone younger than 18.
dermatologists at the School of Medicine,
Cornelius says she and her colleagues
also found that many tanning salon
at the Alvin J. Siteman Cancer Center at
employees across the state said indoor
Barnes-Jewish Hospital and Washington
tanning had no associated risks or would
University School of Medicine routinely see
prevent future sunburns — both false
young, typically female, melanoma patients
claims, according to the study’s authors.
who report previous tanning bed use.
Missouri is one of
“Indoor tanning may
17 states that has no
seem
innocuous at first,”
Ultraviolet rays from the
minimum age restrictions
she says. “Due to what is
sun and artificial tanning
on tanning bed use and
called ‘tumor lag time,’
devices are carcinogenic
does not require parental
or the time between an
consent.
exposure to a carcinogen
to humans, equivalent to
“This should serve as
such as ultraviolet and the
tobacco. — International
a wake-up call for parents
development of a cancer,
Agency for Research on Cancer
in Missouri and other
it may take a decade or
states that don’t regulate
longer for someone who
tanning beds,” says study co-author Lynn
has been exposed to artificial ultraviolet
A. Cornelius, MD, chief of the Division of
radiation to develop a skin cancer.”
Dermatology and the Winfred A. and Emma
For the study, the researchers identified
R. Showman Professor in Dermatology.
831 indoor tanning facilities across Missouri
“With the absence of logical age restricand randomly selected and called 375 of
tions, we are failing to protect our children,
them, posing as prospective clients. For
who are at an increased risk of developing
consistency, the researchers made attempts
skin cancer when exposed to the highto survey each salon twice.
intensity levels of ultraviolet light that can
“Minimizing exposure to ultraviolet
be received in a tanning bed.”
rays, no matter the source, lowers one’s
The findings appeared online Feb. 25
risk of skin cancer,” says Graham A. Colditz,
in Pediatrics.
MD, PhD, a cancer prevention expert at
Exposure to ultraviolet light from
Washington University and the Siteman
tanning beds makes users 75 percent
Cancer Center who wasn’t involved in the
more likely to develop melanoma than
study. “The problem with indoor tanning is
nonusers, and some studies have reported
that users start very young and, unlike the
an increased risk of up to three times,
sun, tanning beds are a completely avoidCornelius says. They’re also up to 2.5 times
able cancer risk.”
outlook.wustl.edu

What Missouri tanning facilities
said in a recent survey

65 % would accept pre-teens
80 % say it prevents sunburns
43 % claim there are no risks
Health recommendations
regarding indoor tanning*
No one under the age of 18
should do indoor tanning
Tanning facilities should post
warnings about health risks
Seek medical advice and get a
skin assessment before tanning
* Guidelines endorsed by the World Health Organization
and the U.S. Food and Drug Administration
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Moving forward

ATCH DAY WAS HELD MARCH 15, 2013,
and 120 graduating medical students
learned their match results from
the National Resident Matching Program.
During the annual ceremony, senior medical
students in the United States learn which
residency programs they will enter.

ALABAMA
Birmingham
University of Alabama
Medical Center
INTERNAL MEDICINE

Jori Ellen May

CALIFORNIA

FAMILY MEDICINE

Ignacio Becerra-Licha
INTERNAL MEDICINE

Brian David Muegge

Stanford
Stanford University Program
INTERNAL MEDICINE

Jeffrey Scott Ketchersid
OBSTETRICS AND GYNECOLOGY

Los Angeles

Sanaa Hasan Suharwardy

Harbor-UCLA Medical Center

George Mark Freeman Jr.

D I A G N O S T I C R A D I O LO G Y

Gregory Randal Bryant

PSYCHIATRYRESEARCH

COLORADO

School of Medicine graduates are highly
successful in obtaining competitive training
programs. In 2013, 34 percent of the graduating
class selected a primary care field and 24 percent
matched into highly competitive specialties,
including dermatology, ophthalmology, surgery,
urology, orthopaedic surgery and otolaryngology.

DISTRICT OF
COLUMBIA
Washington
Georgetown University Hospital
R A D I AT I O N O N C O LO G Y

Ima Paydar

INDIANA

MICHIGAN

Indianapolis

Ann Arbor

Indiana University
School of Medicine

University of Michigan Hospitals

EMERGENC Y MEDICINE

Daniel Nathan Seitz

FLORIDA

IOWA

Miami

Iowa City

Jackson Memorial Hospital

University of Iowa
Hospitals and Clinics

INTERNAL MEDICINE

David Qianli Ying

D E R M AT O LO G Y

Oakland

Denver

Kaiser Permanente Medical Group

GEORGIA

Nicholas Michael
Bontumasi

University of Colorado

Atlanta

Luke Michaud Lowry

INTERNAL MEDICINE

Somalee Banerjee

D E R M AT O LO G Y

David Richard Pearson

San Diego

Fort Collins

Navy Medical Center

Fort Collins Family
Medical Program

P E D I AT R I C S

Tammy Sue Shirley

University of CaliforniaSan Diego Medical Center
INTERNAL MEDICINE

Adam M. Greenbaum
OBSTETRICS AND GYNECOLOGY

Sarah Campbell Proehl
Amanda Michelle Stewart
OPHTHALMOLOGY

Courtney Lynne Ondeck
PEDIATRICS

YunZu Michele Wang

San Francisco
California Pacific Medical Center
INTERNAL MEDICINE

Laura Alycia Battle

University of CaliforniaSan Francisco
D I A G N O S T I C R A D I O LO G Y

FAMILY MEDICINE

Bethany Amber Davis

CONNECTICUT
Hartford
University of Connecticut
School of Medicine
EMERGENC Y MEDICINE

Tina H. Chen

New Haven
Yale-New Haven Medical Center
D E R M AT O LO G Y

Matthew David Vesely
INTERNAL MEDICINE

Erica Paige Young
OPHTHALMOLOGY

Alexander Thien An
Nguyen

Jason W. Curtis

8 Washington University School of Medicine

Emory University
School of Medicine
EMERGENC Y MEDICINE

Elizabeth Davlantes

HAWAII
Honolulu
University of Hawaii
O R T H O PA E D I C S U R G E R Y 
RESEARCH

Nicholas Christian Foeger

ILLINOIS
Chicago
McGaw Medical Center of
Northwestern University
INTERNAL MEDICINE

Christopher James Adkins
Nicole K. Cibulka
PHYSIC AL MEDICINE AND
REHABILITATION

Abby Ling-Lee Stephens

University of Illinois

EMERGENC Y MEDICINE

MASSACHUSETTS
Boston
Beth Israel Deaconess Hospital
D I A G N O S T I C R A D I O LO G Y

Jeffrey Nelson Dines

A N E S T H E S I O LO G Y

Hank Haw Sun

INTERNAL MEDICINE

Jared Daniel Wilkinson

MISSOURI
Kansas City
University of Missouri-Kansas City
OBSTETRICS AND GYNECOLOGY

Jennifer Ann Reeves

St. Louis
Barnes-Jewish Hospital
A N E S T H E S I O LO G Y

Amrita Aranake
Lara Wiley Crock
D E R M AT O LO G Y

Emily Michelle Beck
William Howard McCoy IV
D I A G N O S T I C R A D I O LO G Y

INTERNAL MEDICINEPRIMARY

Amirali Modir Shanechi
Kevin Andrew Neal
Erin Kerr Romberg

PAT H O LO G Y

Christopher William
Arvind Lawrence

Brigham and Women’s Hospital
Michelle Amanda
Jose-Kampfner

Isaac H.S. Solomon

Children’s Hospital
P E D I AT R I C S

Matthew Raymond Vogt
P E D I AT R I C S  U R B A N
H E A LT H A D V O C A C Y

Kristen Suzanne Grant

Massachusetts General Hospital
PAT H O LO G Y

Kwadwo Asare Oduro Jr.

EMERGENC Y MEDICINE

GENERAL SURGERY

Leisha Carol Elmore
Matthew Robert Schill
Tara Rachelle Skebba
Wen Hui Tan
INTERNAL MEDICINE

Bahaa Ahmad Bedair
Stacy Zhao Dai
Patricia Elizabeth Litkowski
Aaron Joseph Mintz
Nathan Herling Moore
Chelsea Elizabeth Pearson
N E U R O LO G I C A L S U R G E R Y

Santoshi Shalini Indrakanti

GENERAL SURGERY

Guillermo Javier Ares

Spring 2013
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It’s a match! From left: Leisha Elmore; Kathryn Evans and her father, Douglas; and Michael Lee celebrate 2013 Match Day results.
OBSTETRICS AND GYNECOLOGY

Antonina I. Frolova
Jennifer Lee Troyer
Morgan Bernard Wolfe Jr.
O R T H O PA E D I C S U R G E R Y

Christopher Luke
Stockburger
Robert David Wojahn
OTOL ARYNGOLOGY

NEW HAMPSHIRE

NORTH CAROLINA

Lebanon

Durham

Dartmouth-Hitchcock
Medical Center

Duke University

D E R M AT O LO G Y

Mackenzie Capshaw Asel

Tzyy-Nong Tina Liou

NEW MEXICO

PSYCHIATRY

Albuquerque

Andrea Marie
Giedinghagen
Tarik Hadzic
Agnieszka Monika
Milczarek
Carrie Laub Morris
Alecia Cristen
Vogel-Hammen
R A D I AT I O N O N C O LO G Y

Yuan James Rao

St. Louis Children’s Hospital
CHILD NEUROLOGY

Amelia Glatha Drace
P E D I AT R I C S

Jeffery C. Hoover
June Yueheng Hu
Margaret Ashley Young

Saint Louis University
School of Medicine
FAMILY MEDICINE

Betsy Peixi Wan

O R T H O PA E D I C S U R G E R Y

Ugochi C. Okoroafor

NEBRASKA
Omaha
University of Nebraska
Affiliated Hospitals
R A D I AT I O N O N C O LO G Y

Vivek Verma

University of New Mexico
INTERNAL MEDICINE

Tracy Marsh Carlson

NEW YORK
New York
Einstein-Montefiore
Medical Center
OBSTETRICS AND GYNECOLOGY

Mengyang Sun

Icahn School of Medicine at
Mt. Sinai
PSYCHIATRY

Kara Jill Gulewicz

New York Presbyterian HospitalColumbia
A N E S T H E S I O LO G Y

Kurt Joseph Hoffmeister
Dorothy van Oppen

New York Presbyterian HospitalColumbia and Cornell
OTOL ARYNGOLOGY

Kenny Fei Lin

New York University
School of Medicine
R A D I AT I O N O N C O LO G Y

Raymond Bernard Mailhot

St. Luke’s-Roosevelt Hospital
GENERAL SURGERY

Amy Margaret Liang

O P H T H A L M O LO G Y

Andrew Robert Lee

OHIO
Cincinnati
Cincinnati Children’s Hospital
P E D I AT R I C S

Kristen Marie Danley

University Hospital
EMERGENC Y MEDICINE

Charles Elwood Kircher
Matthew Kevin Riddle

Fox Chase Cancer Center
R A D I AT I O N O N C O LO G Y

Yanqun Dong

Hospital of the University
of Pennsylvania
INTERNAL MEDICINE

Nicole Samantha Maloney
PSYCHIATRY

Puneet Kaur Chawla Sahota

St. Christopher’s Hospital
for Children
P E D I AT R I C S  P R E L I M I N A R Y

Colleen Helen Cotton

Thomas Jefferson University
Program
O R T H O PA E D I C S U R G E R Y

Eric Michael Padegimas

Cleveland

Pittsburgh

Case Western Reserve University

University of Pittsburgh
Medical Center

O P H T H A L M O LO G Y

Musa Raed Abdelaziz

Columbus
Ohio State University
Medical Center
A N E S T H E S I O LO G Y

Douglas James Dearth Jr.

OREGON
Portland
Oregon Health & Science
University
EMERGENC Y MEDICINE

Ran Ran

D E R M AT O LO G Y

Kristin Page Bibee
O R T H O PA E D I C S U R G E R Y 
RESEARCH

Rashmi Agarwal

TENNESSEE

PEDIATRICS

Rachel Elizabeth Amthor
Michael Anthony Lee Jr.
PEDIATRICSGLOBAL HEALTH

Yi Wang

University of Texas Medical School
GENERAL SURGERY

Ronald Chang

UTAH
Salt Lake City
University of Utah
Affiliated Hospitals
C H I L D N E U R O LO G Y

Jennifer Ann Hranilovich

WASHINGTON
Seattle
University of Washington
INTERNAL MEDICINE

Michelle Catherine Sabo
OBSTETRICS AND GYNECOLOGY

Vanderbilt University
Medical Center

Nana-Aba Nduom

INTERNAL MEDICINE

Kathryn Meredith Evans
Catherine N. Le
Mona Mashayekhi

Philadelphia

Dallas

Children’s Hospital

University of TexasSouthwestern Medical School
EMERGENC Y MEDICINE

Kavita B. Joshi
P E D I AT R I C S

Krista Renee Whitney
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Baylor College of Medicine

Stephen Andrew McCartney

TEXAS

P E D I AT R I C S

Houston

Nashville

PENNSYLVANIA

Jie Tang

UROLOGY

Varun Sundaram

PSYCHIATRY

WISCONSIN
Madison
University of Wisconsin
O P H T H A L M O LO G Y

Han Kim

CANADA
Toronto
University of Toronto
PLASTIC SURGERY

Maryam Saheb-Al-Zamani
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collaboration
Each dot denotes a faculty member of the
ICTS, and each connecting line represents a
collaboration between faculty in submitting
an NIH grant application. ICTS began in
2007, above, and by 2010, right, there had
already been a dramatic increase in the
number of collaborations and the density of
interconnections among research groups.
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funding
initiative speeds
innovation to
improve health
BY JULIA EVANGELOU STRAIT
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W

hether providing pilot funding to

gather initial data or final funding for projects
heading toward publication, grants awarded
by Washington University’s Institute of Clinical and
Translational Sciences (ICTS) are ultimately aimed at one
goal — supporting medical research that has the highest
likelihood of benefiting patients quickly.
“Facilitating new research collaborations across
traditional disciplinary boundaries is a major goal of
the ICTS,” says director Bradley A. Evanoff, MD, MPH,
assistant dean for clinical and translational research.
“By doing so, new discoveries can more rapidly be
translated into prevention, diagnosis and treatment.”
Washington University’s ICTS is one of 60 such programs
across the country. It is funded through institutional
resources and through a five-year, $50 million Clinical and
Translational Science Award (CTSA) given by the National
Center for Advancing Translational Sciences of the National
Institutes of Health (NIH). In its first six years, the ICTS
has awarded $6.9 million to 70 projects and, in June 2012,
its CTSA grant was renewed for an additional five years.
The ICTS pursues its mission by supporting new research
infrastructure, funding translational research, training
young faculty, and facilitating collaborations across
disciplines. Its research support cores provide expert
consultation and resources in tissue banking, imaging,
biostatistics, biomedical informatics, research ethics,
experimental design, conducting clinical trials, genomic
analysis, regulatory support and community-engaged
research. And that’s just the short list.
Through all of these activities, the ICTS is a pillar of
Washington University’s BioMed 21 initiative, an effort
dedicated to translating basic science discoveries into
solutions for the world’s biggest health problems.
“Our researchers work across departmental and
divisional specialty lines to a greater extent than ever
before,” says Evanoff. “We can’t claim credit for all of
that, but we’ve been one of the forces helping people
make connections.”
Outlook 11

infant care

Kelle H. Moley, MD

mothers’
tissue samples
illuminate
children’s
diseases
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ne example of the school’s connectivity is embodied
in the Women and Infants’ Health Specimen
Consortium, a program led by Kelle H. Moley, MD,
co-director of the ICTS and the James P. Crane Professor
of Obstetrics and Gynecology.
The consortium was founded in 2007 by
Moley and Ann M. Gronowski, PhD, associate
professor of pathology and immunology, with
the help of an ICTS pilot grant. Investigators
from a wide range of specialties are involved,
including pediatrics, microbiology, obstetrics
and gynecology, pathology, internal medicine
and developmental biology.
The purpose of the consortium is to gather
tissue samples from women before and during
pregnancy, after delivery, and from the newborn.
The tissues collected include cord blood, maternal blood, newborn blood, placenta samples and
amniotic fluid.
The samples, which are linked to clinical
reports of the health of the mother and her baby,
are available to investigators interested in a wide
array of issues important to women and newborns, from repeated pregnancy loss, pre-term
delivery and pre-eclampsia to endometriosis
and sexually transmitted diseases. It also may
provide insights into the origins of childhood
diseases and the communication that goes on
between the mother and fetus in utero.
“This resource allows investigators to have
access to unique samples that they would not
normally be able to get on their own,” Moley
says. “We have about 3,000 patients participating
in the program and more than 200 patients that
we have followed throughout the process —
pre-pregnancy, pregnancy, and after delivery.”
Moley co-directs the ICTS in part because
her own research sits at the interface of basic
research in the laboratory and clinical research that can
help patients. An expert in reproductive health, her primary
focus has been endocrine disorders in women, such as those
related to obesity, diabetes and polycystic ovarian syndrome,
and their effects on fertility.
“My work with the ICTS has forced me to think more
about how my own research can be applied to improve
health care,” Moley says. “My job is also to ask other basic
scientists to think about ways that their research can affect
human health directly and to encourage them to become
involved with the ICTS.”
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Randall S. Sterkel, MD, and Jane M. Garbutt, MBChB

aiming for
consensus in
private
practice
clinical care
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aking medical research into the community and helping physicians in private practice is another goal of the
ICTS. Jane M. Garbutt, MBChB, research associate professor
of medicine and pediatrics, has been a pioneer in this effort.
Many times care for common conditions, such as sinus
infections or pinkeye, differs greatly from one
doctor to the next. To help determine the best
solutions for these typical ailments, Garbutt
established the ICTS-supported Washington
University Pediatric and Adolescent Ambulatory
Research Consortium (WUPAARC), a network
of local pediatricians in private practice who are
interested in improving clinical care.
“We try to make our research relevant and
useful to primary care doctors,” Garbutt says.
“If you just conduct research studies in academic institutions, the patients may not be
representative of the patients going to see their
regular doctors. If we recruit patients through
primary care practices, we get more diversity
in the patient mix.
“And the results will be relevant to other
doctors with similar practices. The physician
can look at these studies and say, ‘These patients
look similar to mine, so the results should apply
to them, therefore I will change my practice.’”
Currently, 66 pediatricians and five nurse
practitioners from 35 medical practices in the
St. Louis area participate in WUPAARC. The
pediatricians themselves suggest the questions
to be studied by the consortium.
One ongoing trial is looking at whether
peer coaching delivered by telephone for
mothers of children with asthma will help
better control the disease. Asthma coaches
help the mother develop a collaborative
relationship with the child’s doctor and
provide education and support to encourage
effective use of asthma medications.
Garbutt’s own research is focused on improving the
quality of care in the ambulatory setting. She shares her
expertise in these community-based research methods and
logistics with other investigators at the university so that
they might also begin studying ways to improve health
care in the wider community setting, where so many people
receive their medical care.
“The success of any research network is dependent on
personal relationships,” Garbutt says. “We have to build a
network that transcends one study. We have to build the
relationships and structure needed for research and then
nurture it.”
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Matthew J. Ellis, MD, PhD

modeling
deadly cancers
may lead
to new
treatments
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A

long with its commitment to community-based

research, the ICTS also supports work that is done in
animal models of disease with a clear pathway to improving
human health. One example is a core resource devoted to
studying human breast cancer tumors in living organisms.
The Human and Mouse Linked Evaluation of
Tumors (HAMLET) Core is led by breast cancer
expert Matthew J. Ellis, MD, PhD, director of
Breast Oncology at Washington University
and co-leader of the Breast Cancer Research
Program at the Alvin J. Siteman Cancer Center
at Barnes-Jewish Hospital and Washington
University School of Medicine.
With this resource, researchers can study
living tumor cells in a preclinical model. The
growing tumors are genetically similar or identical to the original tumor and they provide excellent test subjects for developing new imaging
techniques and performing early studies of new
drugs and therapeutics.
A major success stemming from this relatively new core resource culminated in a paper
published in Nature in 2010. The study looked
at four DNA samples from a single patient with
basal-like breast cancer, an aggressive form of
the disease more common in younger women
and African-American women. The four samples
came from the patient’s primary tumor, peripheral blood, a brain metastasis, and a primary
tumor sample grown by the HAMLET Core.
The HAMLET Core tumor differed in
important ways from the primary tumor and
had remarkable similarities to the tumor that
had spread to the patient’s brain. Such evidence
sheds light on the mystery of how cancer metastasizes and suggests that a small number of cells
in the main tumor can give rise to secondary
tumors that spread throughout the body.
“Basically what’s growing in the mouse is another metastasis — the most malignant version of the tumor,” Ellis says.
“So this resource is helping us model the most deadly types
of breast cancer, and that’s what we need to focus on. We
want to make these models freely available and collaborate
widely to solve an extremely complicated biological problem.”
Since the Nature study, an additional 16 models have been
deeply sequenced and those findings were released at the
recent American Association of Cancer Research meeting.
The findings show that human-in-mouse copies of breast
cancer are very clearly excellent genomic and functional
mimics of the disease. The approach is so promising that
the HAMLET Core plans to expand and include additional
tumor types, likely starting with pancreatic cancer.
Spring 2013
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more investigators take advantage of the university’s
existing technology. A prime example is the ICTS Human
Imaging Unit, housed in the Center for Clinical Imaging
Research (CCIR) in the Mallinckrodt Institute of Radiology.
The ICTS Human Imaging Unit is led by
Robert C. McKinstry, MD, PhD, professor
of radiology and of pediatrics, and provides
access to five state-of-the-art imaging scanners.
Pamela K. Woodard, MD, professor of radiology
and of biomedical engineering, leads the CCIR.
“We want to make sure researchers know
that this resource is available to them and that
funding opportunities exist to support pilot
projects that can then be used to apply for larger
grants,” Woodard says. “Our equipment is dedicated to research, making it easier to schedule
time on the machines.”
As important as access to the scanners
themselves, the Human Imaging Unit connects
researchers with expert radiology staff and
faculty, making it possible for investigators to
use the equipment regardless of their level of
experience with human imaging.
In one example, the Human Imaging Unit
helped develop imaging methods to evaluate
how well the placenta is functioning in late
pregnancy. “The researcher wanted to investigate the health of the placenta and how that is
affecting the fetus in utero,” McKinstry says.
“So our staff helped him develop a protocol to
measure placental morphology, size and chemical makeup for clues as to whether the placenta
is ‘running out of gas’ and putting the fetus
at risk. The investigator knew the question he
wanted to answer, but he didn’t know how to
use imaging to answer it.”
The scanning tools also let researchers
image a beating heart in near real time; easily distinguish
bone, soft tissue and fluid; and create two- and threedimensional images. The equipment includes two MRI
scanners, a CT scanner, a combined PET-CT machine and
a PET-MRI system.
Because imaging is often a key bridge between animal
studies and human application, the CCIR serves an important role in translating basic science from preclinical areas
into clinical research areas. The CCIR is one of only five
or six facilities in the United States that has a PET-MRI
machine. Cutting-edge instrumentation like the PET-MRI,
as well as the presence of multiple high-end imaging systems
all in close proximity, make the CCIR a world-class
translational imaging research facility, says McKinstry.
Outlook 15

SKIN
IN F E C T I O N S

BL I N D N E S S

D

NERVE
DAMAGE

COM

FOOT
AMPUTATION

KIDNE Y
DIS E AS E

HE ART
FAILURE

FERTILITY
PROBLEMS

16 Washington University School of Medicine

DEPRESSION
FATT Y LIVER
DISEASE

IABETES

A growing epidemic.
A spectrum of diseases.
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as many as one in three American adults could have diabetes by
2050. This growing problem — U.S. Centers for Disease Control
has called it “an emerging epidemic” — is already impacting an
alarming number of people nationwide.
Nearly 26 million individuals in the United States are living
with diabetes — an estimate that includes roughly 7 million
people who remain undiagnosed. Among those age 65 and older,
almost one in four have diabetes. The cost of diabetes, now over
$100 billion annually, will likely grow along with the prevalence
of the disease.
It’s this looming health crisis that drives the School of
Medicine’s Diabetes Research Center (DRC). Located in the
Department of Medicine and now in its 36th year of National
Institutes of Health (NIH) funding, the DRC is a hub for multidisciplinary collaborations, making steady progress in uncovering
the mechanisms involved in diabetes and its complications.
Washington University’s DRC is one of 16 centers supported
by the National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK). Its established and comprehensive research
bases in diabetes and related areas of endocrinology and
metabolism ensure that scientific investigation is evolving to
meet this major public health challenge. C O N T I N U E D O N P A G E 2 0 »
BY LEE PHILLION
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The ravages of diabetes

HE A D TO TOE
If you think only of blood sugar when you think
of diabetes, think again. Consider how diabetes
affects the entire body: If not carefully managed,
it can quickly become life-threatening. The
Diabetes Research Center at Washington
University brings together experts from diverse
disciplines to understand the systemic effects
of this increasingly common disease.

Vital key
Like a pass key, the hormone insulin
opens the door, enabling cells
to use glucose delivered by the
bloodstream. Without this key, this
important fuel cannot be efficiently
used and stockpiles in the blood.

GLUCOSE

LIPIDS

Lipid overload
Insulin is also an important key to
fat metabolism. Without appropriate
insulin action, fats build up in
tissues and the bloodstream.

Type 1 diabetes results
after an overactive immune
system destroys insulinproducing cells in the
pancreas and leads to
insulin deficiency. An energy
crisis ensues: Despite high
circulating blood sugar levels,
cells in the body cannot
effectively use the sugar
without insulin injections.

T YPE

Genetic factors, inactivity,
poor diet and weight gain
can lead to metabolic
imbalances and resistance
to insulin action. Initially
insulin levels increase to
compensate. However,
blood sugar levels rise as
the pancreas fails to make
enough insulin to
overcome this resistance.

Body-wide affects
NERVOUS SYSTEM
Nerve damage leading to pain,
loss of sensation, abnormal
neuroregulation
MENTAL HEALTH
Depression, emotional distress
VISION
Glaucoma, cataracts, retina
disorders leading to blindness
ORAL HEALTH
Gum disease
GASTROINTESTINAL SYSTEM
Fatty liver disease
C ARDIOVASCULAR
SYSTEM
Heart attack, peripheral
vascular disease, hypertension,
stroke, heart failure
URINARY SYSTEM
Urinary tract infections,
kidney failure
GESTATION
Pregnancy complications, fetal
developmental abnormalities,
health risks passed on to children
SEXUAL HEALTH
Menstrual irregularities, fertility
problems, hormonal imbalances,
erectile dysfunction
FEET
Sensory diminishment,
skin changes, ulcers leading
to amputation
SKIN
Infections
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DIABETES

COMPLICATIONS
A brief tour of major organs affected by complications of

ROBERT BOSTON

Diabetes complications can include
blurred vision caused by damage to
the retina and bleeding within the
eye fluid. A treatment performed
by Rajendra S. Apte, MD, PhD, takes
place under subdued red lighting,
permitting his precise visualization
of a few millimeters of tissue while
allowing the surgical team to see
within the darkened room.

As director of the Diabetes Research Center (DRC),

Jean E. Schaffer, MD, the Virginia Minnich Distinguished
Professor of Medicine, has a panoramic view of research
underway at Washington University aimed at understanding
and finding treatments and ultimately a cure for diabetes.
Schaffer spearheaded the recent competitive renewal for
NIH funding that will propel the DRC forward for the next
five years.
The DRC’s 111 members from across the school have
joined forces around intersecting areas of interest to understand the basic processes involved in diabetes and its complications and to translate discoveries into better patient
care. DRC funding provides support for technical expertise
in state-of-the-art core facilities, a robust pilot grant program to jump start the most exciting new ideas in diabetes
research, and a vibrant enrichment program of seminars
and courses that stimulates the exchange of ideas.
“Multidisciplinary research is the paradigm for the
DRC,” says Schaffer. “The systemic, chronic and complex
nature of diabetes requires a multidimensional approach,
and our members are working across the spectrum of
immunology, metabolic regulation, and the end-organ
complications of diabetes.”
20 Washington University School of Medicine

diabetes illustrates the scope of investigations connected
through the DRC. The tour begins with the most complex
organ — the brain. Weighing in at just 2 percent of body
mass, the brain accounts for 25 percent of body glucose
utilization, and fluctuations in glucose supply to the brain
can dramatically affect its function.
Tamara Hershey, PhD, professor of psychiatry,
neurology and radiology, uses sophisticated in vivo brain
imaging coupled with neurobehavioral measurement techniques to determine how exposure to glycemic extremes
impacts brain structure and function in children and adults
with type 1 diabetes.
Hershey also leads the first long-term group study
of brain vulnerability in Wolfram Syndrome, a rare
monogenic form of juvenile-onset, insulin-dependent
diabetes that is associated with neurological complications including early blindness. This longitudinal study leverages advances in the diagnosis and
molecular underpinnings of the syndrome made by
the late M. Alan Permutt, MD, the former director of
the DRC, and Fumihiko Urano, MD, PhD, the Samuel
E. Schechter Professor of Medicine.
This study of Wolfram Syndrome patients will identify
biomarkers and support clinical trials of specific treatment
agents and serve as proof-of-principle for more genetically
and environmentally complex forms of diabetes.

Our next stop is the eye. Diabetic retinopathy, caused by

changes in the blood vessels behind the retina, is seen in
up to 45 percent of people diagnosed with diabetes and is a
leading cause of blindness in adults.
“Eye health is directly correlated to glycemic control in
diabetic patients,” says Rajendra S. Apte, MD, PhD, the Paul
A. Cibis Distinguished Professor of Ophthalmology and
Visual Sciences. “Sometimes it is the eye specialist who first
diagnoses the disease from its complications in the eye.”
Apte has found that immune cells called macrophages
regulate the development of damaging blood vessels in not
only diabetic retinopathy, but also in age-related macular
degeneration and in retinopathy of prematurity (formerly
known as retrolental fibroplasia), which affects prematurelyborn babies.
Apte’s research into the molecular factors that lead to
macrophage changes may open new opportunities for costeffective treatments of all of these conditions.

Cardiovascular disease is the leading cause of death in

patients with type 2 diabetes, and the DRC has an impressive
depth and breadth in understanding diabetic cardiovascular
complications. Carlos Bernal-Mizrachi, MD, assistant professor of medicine and of cell biology and physiology, has demonstrated the importance of vitamin D deficiency in patients
with type 2 diabetes.
Spring 2013

“Low vitamin D levels nearly double these patient’s relative risk of developing cardiovascular disease,” notes BernalMizrachi. His work has revealed new insights into the
mechanisms that link vitamin D signaling in immune cells
to cholesterol deposition and atherosclerotic plaque development in diabetes.
Bernal-Mizrachi is the principal investigator of two randomized controlled interventional trials to assess the effect
of vitamin D supplementation on blood pressure and subclinical markers of cardiovascular disease in diabetes.
Cardiologist Sharon Cresci, MD, assistant professor
of medicine and genetics, wants to understand
why patients with diabetes suffer from a more
aggressive form of heart disease. Lever-aging

after surgery and achieve a 10-fold decrease in acute rejection rates, both of which improve long-term outcomes.
“Over the last eight years, our transplant team has also
steadily increased the number of kidney-pancreas transplants or pancreas transplants alone for selected patients,”
says Brennan. “These provide better diabetes-related and
overall quality-of-life improvements.”
Program surgeons perform around 220 kidney transplants and between 15 to 20 combined or sequential kidneypancreas transplants annually. While the majority of patients
who undergo sequential kidney-pancreas transplant have
type 1 diabetes, data suggest that the procedure also confers
significant benefits for some patients with type 2 diabetes.

Systemic, chronic and complex, diabetes
requires a multidimensional approach.

is a visit to the laboratory of Kelle H. Moley, MD, the James
P. Crane professor of obstetrics and gynecology, who is an
expert in reproductive endocrinology and infertility.
Men with diabetes can suffer testicular dysfunction, impotence and decreased fertility. In women, diabetes and obesity
are associated with an increased risk of reproductive complications, including fetal loss and congenital malformations.
Moley’s research has provided key insights into the
consequences of early fetal exposure as well as preconception
gamete exposure to high concentrations of glucose, insulin
and/or fatty acids and the effects of the drug metformin
on miscarriages. Her work has improved understanding of
pregnancy failure among women with diabetes. Other recent
work suggests that systemic insulin insufficiency and resulting decreased hypothalamic-pituitary-testes axis signaling
are the key detrimental factors responsible for subfertility
among diabetic men.

The final stop on the complications of diabetes excursion

her background in cardiovascular disease,
metabolism and genetics, Cresci helped
design a custom microarray chip that she then
used to discover the first genetic variant associated
with severity of coronary artery disease in patients
with type 2 diabetes. Findings such as these hold promise for
more effective clinical management through genotype-based
personalized treatments.
These types of clinical investigations are complemented
by groundbreaking basic discoveries in the effects of diabetes
on blood vessels and heart muscle in the laboratories of
investigators including Clay F. Semenkovich, MD, the
Herbert S. Gasser Professor and co-director of the DRC.
Moreover, the concentration of research excellence in the
area of diabetic heart and vascular complications spurred
the formation of the Diabetic Cardiovascular Disease Center
(DCDC), one of the school’s BioMed 21 interdisciplinary
research centers. Institutional resources for the DCDC, co-led
by Schaffer and Daniel S. Ory, MD, professor of medicine
and of cell biology and physiology, have proven instrumental
for several recent successful NIH funding applications for
diabetic complications research at Washington University.
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Diabetic nephropathy is another common and devastating
complication that can result in end-stage renal disease. DRC
member Daniel C. Brennan, MD, professor of medicine,
leads one of the most experienced kidney transplant and
transplant nephrology programs in the United States.
Nationally, approximately one-third of kidney transplant
patients present with diabetes. And of those who do not, up
to 20 percent will develop diabetes within a year after transplant. By studying new immunosuppressants and induction
agents, Brennan’s team has been able to reduce post-transplant onset of diabetes to just 5 percent within the first year

Daniel C. Brennan, MD,
follows up with patient
Padma Jampala, who
underwent a successful
kidney transplant in 2004.
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Getting different professions
talking — and working —
together, for the greater good
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TIM PARKER

Students from diverse training
programs work together to answer
questions posed by faculty during a
recent case study presentation.
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nterdisciplinary teamwork in health care isn’t just a
concept — it’s a reality. The constantly evolving nature
of the U.S. health care system makes well-coordinated
collaborations across medical professions a necessity.
At Washington University School of Medicine, students
from multiple programs are actively building bridges
among professions even before they begin their careers.
The Health Professionals Student Leadership Council
(HPSLC) was created by students in 2010 to promote
and advance the understanding of collaboration among
professions in providing effective patient care.
“HPSLC has three main goals,” explains group president Michele Ionno, a second-year student in the school’s
Program in Physical Therapy. “The first is to improve communication among students from various disciplines. The
second is to improve knowledge of what each discipline
offers in the clinic. Third, and most importantly, we want to
show students how working together improves patient care.”
The group includes Washington University students
from the medical, occupational therapy, physical therapy,
audiology and communication
sciences, and Division of Biology
and Biomedical Sciences
programs, and students
from the St. Louis College
of Pharmacy and the
Goldfarb School of Nursing
at Barnes-Jewish College.
Although HPSLC’s members are located on or near
the Washington University
Medical Center campus,
opportunities for students
to interact has been limited.
HPSLC is determined to
change that. The group regularly brings members from all
of the professions together at
various academic and community outreach events.
These include featured lunch
talks, an activities fair, case
study reviews, and an annual
Community Service Day.
Spring 2013
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“Each profession
has its own
language and
frame of reference.”
—SARAH CHEATHAM OBERLE, OTD ’13

health
interaction
team

During case study reviews, faculty pose questions to
working on her master’s degree in deaf education. “I moved
interprofessional groups of students.
here from Michigan and have found that many students tend
“Each round of questions represents a different setto stick to their own programs for socializing. But I feel that
ting for the patient as he or she moves through the health
I met people who have become some of my greatest friends
care system,” explains Gloria Grice, associate professor of
at Community Service Day.”
pharmacy practice and associate director of experiential
Script Your Future, a national campaign HPSLC recently
programs at the St. Louis College of Pharmacy (STLCOP).
participated in, gave students from all of the professions
“It’s fun for the students because they are all very competiopportunities to meet with community members at more
tive and enjoy being challenged, but it’s not ‘high stakes’
than 24 locations to address concerns about medication
like their actual coursework.”
adherence and its importance in maintaining good health.
Third-year medical student and former HPSLC president
“Each profession has its own language and frame of
Elaine Khoong agrees. “All the students
reference,” says HPSLC vice president
really enjoy the experience. Not only is
Sarah Cheatham Oberle, a second-year
it informative and instructive, it’s also
student in the school’s Program in
synergistic with the formal curriculum
Occupational Therapy. “We want our
in that it helps us become better prepared
students to work with other practitioners
to apply what we have learned in the
to learn the language they speak and
classroom to what we will eventually
what they bring to patient care. We need
do in clinical practice.”
to work together as a team to provide
Community Service Day, held early
continuity of care for our patients, and
in the academic year, is geared toward
we really believe that mindset needs to
first-year students. It promotes collabstart in graduate school.”
oration among students in the different
Cheatham Oberle has been active in
programs as well as community-building
developing HPSLC’s shadowing program,
in the city of St. Louis.
which provides an opportunity for stuCommunity Service Day
“It’s really important for students to
dents to meet and observe practitioners
brings students together.
know how to interact as professionals,”
from professions other than their own.
says Lauren Lewis, a second-year student
While the list of participants is relatively
in the school’s Program in Audiology and
small, the group is actively recruiting
for additional mentors. Expanding the shadowing program
Communication Sciences (PACS) and secretary of HPSLC,
and continuing to build on other successful initiatives are
“but also on a more personal level to get to know one
another. And it’s great to be welcomed into the community
top priorities for HPSLC.
“Collaborative learning leads to teamwork in the realnot only as clinicians, but as people who can give back to the
world health care setting and, most importantly, improves
city in which they live.”
In 2012, more than 120 students in teams of 10 worked
patient care by increasing coordination of services,” says
with established community organizations at a variety of
Alison J. Whelan, MD, senior associate dean for education.
sites — from participating in a neighborhood cleanup with
“Collaboration also has implications for the bottom line, in
that more efficient care maximizes prevention, which may
members of St. Louis Arc, a group that supports people with
then decrease the burden on acute care facilities.
developmental disabilities, to painting and assisting with
childcare at Lydia House, which provides transitional hous“Washington University School of Medicine students
and their peers in HPSLC are prepared to meet the need
ing for abused women and children.
for enhanced collaboration, and by embracing the need for
“For incoming students, Community Service Day is a
great way to get to know St. Louis and the wonderful organiteamwork across multiple professions, they are actively prezations that are established here,” says Casey Krauss, who is
paring to meet the health care challenges of the future.”
outlook.wustl.edu
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viewpoint

ClassCLOWN

Seriously, folks!
Clown arts enhance
the healing arts.
BY JUDY MARTIN FINCH
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ROBERT BOSTON

C

all Keland Scher a clown and he’ll consider it a
compliment. Accuse him of clowning around in the
classroom and you’ll be technically accurate. Scher,
a master’s degree candidate in occupational therapy set to
graduate this May, wholeheartedly embraces the art of play.
Scher’s educational background and life experience are
a bit different compared to the majority of students in the
School of Medicine’s Program in Occupational Therapy.
Before coming to Washington University, he earned a
diploma from Ringling Bros. and Barnum & Bailey Clown
College in Florida and, after graduation, “rode the rails” for
a year performing. He also worked for five years with the
Big Apple Circus Clown Care unit in hospitals, nursing
homes and camps for children with life-threatening illnesses.
In addition to his clowning credentials, Scher also holds
a bachelors of fine arts in theatre from Miami of Ohio
University and a masters of fine arts and a teaching of movement for actors’ diploma from York University in Toronto.
He had planned a career as an actor and teacher. But
while teaching a movement for performance class to students at Roosevelt University in Chicago, Scher realized he
cared more about the classes that were physically benefiting
students than how they could integrate those movements
into the characters they portrayed.
“I knew I wanted to find a therapeutic container for all the
work I was doing,” says Scher. “That’s when I came upon an
article in the Australian Occupational Therapy Journal and
realized that occupational therapy would fit the bill.”
He applied to several schools, but quickly
chose the Program in Occupational Therapy
at Washington University due to its sciencebased nature and high ranking.
Once in St. Louis, Scher knew he’d made
the right decision. “The faculty has been supportive by allowing me to take my skill as a
teacher and circus artist into research,” he says.
Scher recently completed a study involving participants from Central Institute for
the Deaf (CID), with Meredith Gronski,
OTD, OTR/L, serving as his mentor. “Dr. Gronski opened
up her research lab to circus arts,” Scher says. “It takes a
trusting soul in a medical school to allow this.”
According to Scher, previous research has shown that
children who are deaf or hard of hearing have difficulty with
basic communication skills such as collaboration or social
participation. Scher developed a 10-week course to determine how using circus arts as an intervention could help
these children to improve their social skills, tapping into
their motivation and encouraging self-efficacy.
Working mainly with eight- to 12-year-olds, Scher set
about teaching the children how to juggle, spin plates, walk
and balance on a giant ball, and work together to build a
pyramid. The study culminated with a 40-minute performance for the participants’ parents and teachers.

Keland Scher performs at a recent coffehouse event held at the School of
Medicine’s Farrell Learning and Teaching Center.

“Keland came to the Program in Occupational Therapy
with a passion for circus arts,” says Gronski. “He knew from
his experiences that they have tremendous therapeutic value
— he just needed an avenue to prove it. When he approached
me with this idea, I was admittedly hesitant. It was ‘outside the box’ of the intervention I currently provide at CID.
However, the collaboration could not have had better results.”
Scher presented his research findings at the program’s
annual scholarship day and at the American Occupational
Therapy Association’s annual meeting held in April.
Among the qualitative results were teachers’ comments,
which suggest that the children who participated grew in
confidence. One teacher noted “…[the children] were very
proud of themselves ... and they learned that dropping a ball

“I enjoy empowering others through

TIM PARKER

physical and vocal expression, helping them to grow,
change and transform. Occupational therapy in
tandem with circus arts has the potential to be a
powerful combination.” — Keland Scher, MSOT ’13
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meant another opportunity to try again, not failure.”
Scher considers himself fortunate to be able to bring
his experience in teaching and his passion for circus arts
together while at Washington University, while Gronski considers the program fortunate for Scher’s innovative thinking.
“Children who are deaf and hard of hearing often transition into public educational arenas with hearing peers,”
says Scher. “The more opportunities they have for social
interactions that foster trust, mutual respect and positive
risk-taking, the better equipped they will be to succeed.”
Gronski agrees. “Not only did Keland foster these skills
in the children at CID, but he really is pushing the field of
occupational therapy forward. And accommodating his
project exemplifies the Program in Occupational Therapy’s
commitment to innovative practice.”
Outlook 25
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Understanding
the brain

BY STEPHANIE STEMMLER
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The timing is right to advance the field of neurosciences.

Janice W. BrunstromHernandez, MD, director
of the Pediatric Neurology
Cerebral Palsy Center, with
young patient Bryn Adams
and her dad, Keith.

The number of people affected by degenerative brain diseases is
growing as the population ages, while mental illness affects 1 in 4
adults and 1 in 5 children in the United States. In multiple ways,
we see the physical, emotional, and financial toll of brain disorders
and diseases upon society.
Our researchers have developed a highly accurate diagnostic
tool for autism and are homing in on the disease’s genetic triggers.
We are leading worldwide clinical trials to test new drugs that may
prevent or halt the progression of Alzheimer’s disease and dementia.
Investigators at Washington University are leading a coalition of
scientists who are undertaking the effort to map the human brain.
At the School of Medicine, there is a confluence of research
expertise and a rich legacy of pioneering advances in neurosciences
that goes back more than 50 years. Diverse collaborations are
underway in fields such as neurosurgery and neurology, psychiatry,
neuroimaging, molecular biology, and pathology — all trying to
unravel the enigma that is the human mind and brain.
The field of neurosciences is poised to make significant
medical advances over the next two decades. With your support, we
can lead the way in this important area of research and clinical care.

We invite you to be a part of this historic endeavor.

outlook.wustl.edu
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Barbara and Andrew Taylor support ongoing research into the diagnosis, treatment, and prevention of mental illness.

A mental health focus
Realizing that the stigma needs to be lifted

from the diagnosis of mental illness, Andrew
and Barbara Taylor and the Crawford Taylor
Foundation recently committed $20 million to
the Department of Psychiatry at Washington
University School of Medicine to advance research
into the diagnosis and treatment of mental illness.
“Our own families have been touched by
these illnesses over several generations,” says Andrew C. Taylor, chief
executive officer and chairman of
Enterprise Holdings. “In the news,
we hear of so many tragedies involv“We put our family name
ing mental illness. We, as a country,
front and center because
need to become better informed
we thought it could be a
and support the research going on
beacon, that it might attract
that can better treat or prevent
these diseases.”
interest both in psychiatry
The generous gift will support
and philanthropy.”
the establishment of the Taylor
— ANDREW TAYLOR
Family Institute for Innovative
Psychiatric Research.
“Our department has played
a leading role in advancing criteria-based
psychiatric diagnoses, and we’re now focused
on finding new treatments as well as trying to
better understand the mechanisms that trigger
these disorders in the brain,” says Charles F.
28 Washington University School of Medicine

Zorumski, MD, the Samuel B. Guzé Professor
and head of the Department of Psychiatry.
“Psychiatry has a huge problem in that current treatments are good, but not good enough
for a significant number of people who either
don’t respond to current medications or experience serious side effects,” says Zorumski, who
also is a professor of neurobiology. “There is an
incredible message in the gift from the Taylor
family in that they want us to find better treatments to help those with mental illnesses who
often have no other voice in society.”
“We put our family name front and center
because we thought it could be a beacon, that it
might attract interest both in psychiatry and the
world of philanthropy,” says Taylor. “It’s going
to take more gifts, large and small, to accelerate
research into psychiatric disorders, and my hope
is that this will yield another class or several
classes of medications that can better address
these illnesses.
“Since this gift was announced, I have
received notes from people around the country
who have been impacted by mental illness. What
they tell me is that they now have a sense of hope
— someone is paying attention. I want many
people to pay attention because I think awareness
promotes momentum.”
Spring 2013

David M. Holtzman, MD, with patient Lynn Burlingame in the Charles F. and Joanne Knight Alzheimer’s Disease Research Center.

Defeating Alzheimer’s
The first worldwide human testing of
three investigational drugs to determine if they
can prevent Alzheimer’s disease dementia is being
led by researchers at Washington University.
The trial involves 240 people, all from families with rare inherited genetic mutations. Those
who inherit the mutation are certain to develop
Alzheimer’s. The academic medical centers
involved with the trial are connected
through an international research
study, the Dominantly Inherited
Alzheimer Network (DIAN), led by
John
C. Morris, MD, the Harvey A.
“We want to prevent
and Dorismae Hacker Friedman
damage and loss of brain
Professor of Neurology and director
cells by intervening early
of the Charles F. and Joanne Knight
in the disease process
Alzheimer’s Disease Research Center.
“As more and more baby boomers
— even before outward
move into this age of 65 and older,
symptoms are evident.”
we’ll see an explosion of people with
— RANDALL J. BATEMAN, MD
Alzheimer’s disease and dementia,”
says Morris, calling it a public health
disorder of epidemic proportions.
“We want to prevent damage and loss of brain
cells by intervening early in the disease process
— even before outward symptoms are evident,”
says Randall J. Bateman, MD, the Charles F.
and Joanne Knight Distinguished Professor of
outlook.wustl.edu

Neurology and principal investigator of the grant
and director of DIAN.
Washington University has been leading the
field of Alzheimer’s disease research for more than
20 years. It is here that scientists discovered that
degenerative changes in the brain begin 15 years
before signs of dementia become apparent.
”There are an estimated 5.5 million people
with dementia due to Alzheimer’s right now,”
says David M. Holtzman, MD, the Andrew B.
and Gretchen P. Jones Professor and chair of the
Department of Neurology, “and that number is
expected to triple by 2055.”
Basic research has shown that the build-up of
two proteins in the brain, one somehow triggering
the accumulation of the other, occurs in patients
with Alzheimer’s. Holtzman’s lab and others are
working to find ways to decrease the build-up of
both of the proteins. An added hope is that a fast,
reliable measure, such as a blood test, will allow
diagnosis of Alzheimer’s disease early enough so
that new medications can stop the accumulation of
proteins and thus prevent brain degeneration.
“We hope these new drugs not only hit the
target protein but also slow the process of degeneration,” Holtzman says. “Because of research
now underway, there is definite hope that at some
point we will be able to prevent this disease.”
Outlook 29

John N. Constantino, MD, far right, with the Al-joundi family, from left: Jumana, Mohamad, Bassam, and Nizar.

Success with autism
With non-identical twin teen boys, both

diagnosed with autism, Bassam and Jumana
Al-joundi have tried for years to find care,
ongoing treatment, and hope.
“Having two children with autism is a huge
responsibility to myself, God, my husband, and
my boys,” says Jumana Al-joundi. “It is very
challenging, but I could never imagine myself or
my life without them.” Her husband, Bassam N. Al-joundi, MD,
agrees. “As parents, we try anything
we can to help our children,” he
says.
“It’s been a long struggle.”
“Having two children
The Al-joundis’ situation mirrors
with autism is a huge
studies that show some 15 percent
responsibility. It is very
of families who have a child with
autism have a second child with the
challenging, but I could
same disorder, sparking investiganever imagine myself or
tion into autism’s genetic risk factors.
my life without them. ”
In groundbreaking research,
Washington
University psychiatrists
— JUMANA Al-JOUNDI
identified subtle social deficits, language impairments, and repetitive
behaviors in many unaffected siblings of children
with autism. This provides important clues about
how autism is transmitted in families.
“What’s equally surprising is how these traits
‘travel together’ in children without autism; they
30 Washington University School of Medicine

are as tightly correlated in siblings and in the general
population as in the autistic syndrome itself,” says
John N. Constantino, MD, the Blanche F. Ittleson
Professor of Child Psychiatry and co-director of
the Intellectual and Developmental Disabilities
Research Center.
“The strong connection between these seemingly different aspects of behavior was our first clue
that what goes awry in autism is an extreme version of what results in normal variation in social
development,” says Constantino. “The science of
autism, then, is really the study of human social
behavior, where autism represents the extreme of a
developmental continuum.”
Constantino and his colleagues are trying
to determine why more boys than girls develop
autism and how autism risk is transmitted in
families, often through unaffected parents. Other
Washington University researchers are conducting
brain-imaging studies on infants at risk for developing autism to see if early signs of the disease can
be pinpointed.
“This city needs a comprehensive autism
center and coordinated resources to help families like ours over the long term,” says Bassam
Al-joundi. “Research is important, but the added
emphasis that Washington University will put on
treatments and care for autistic children is vital.”
Spring 2013

Alan Pestronk, MD, director of the Neuromuscular Division, with patient Gretchen Miller in the neurology clinic.

Neuromuscular study
Diseases of the muscles and nerves

range from the uncommon to the very familiar.
Common symptoms include weakness and sensations of numb or tingling hands and feet.
In just the last several years, researchers at
Washington University have discovered new
genetic forms of neuromuscular diseases — a
variant form of amyotrophic lateral sclerosis
(ALS), commonly known as Lou
Gehrig’s disease, and disorders that
cause muscle and nerve damage.
These discoveries point to a
“Just by looking at muscle
nationally recognized strength of
through the microscope, the School of Medicine’s neurowe can tell the kinds of
muscular program. “We have the
combined
strength of one of the
myopathies patients are
busiest clinical programs for the
likely to develop and which
care of patients and a large neurotreatments are likely
muscular physician research group,”
to be effective.” says Alan Pestronk, MD, director
of the Neuromuscular Division.
— ALAN PESTRONK, MD
Researchers in the division
explore the genetic and autoimmune
causes of often devastating diseases that strike
nerves or muscles, such as ALS, muscular dystrophy, myositis, and immune and hereditary nerve
disorders. Because many of these diseases are
uncommon, researchers have created a DNA bank,
outlook.wustl.edu

a collection for use in ongoing studies that includes
genetic information from thousands of patients.
Focused efforts on the genetic causes of ALS
point to single mutated genes that produce a toxic
protein. “We now are testing a chemical compound that blocks the production of one such toxic
protein in human patients,” says Pestronk. “The
studies are generating hope that we can treat some
forms of ALS, which currently have no cure.”
Researchers also have identified a serum antibody that may point to the cause of some previously unexplained, painful neuropathies, opening
the door to the development of new drug therapies.
More than a decade of research into the autoimmune causes of chronic muscle inflammation
and weakness has led to the creation of an exciting and specific muscle biopsy diagnostic process.
“Just by looking at muscle through the microscope, we can tell the kinds of myopathies patients
are likely to develop and which treatments are
likely to be effective,” Pestronk says.
More funding would enable the division
to accelerate efforts to identify the genetic and
immune triggers for neuromuscular diseases.
“In many diseases that we treat,” says Pestronk,
“we are getting better ideas of the molecular
mechanisms that cause them, which means
effective treatments are closer to reality.”
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Alison Goate, PhD, left, who studies protein aggregation and neurodegeneration, with postdoctoral student Celeste Karch.

Collaborative efforts
Brain diseases such as stroke, Parkinson’s

disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease
are among our nation’s most significant health
problems, affecting 50 million Americans. More
research is needed if we are to treat these illnesses
more effectively and someday even prevent them.
“I would not be here if medical research had
not extended my life,” says
William H. Danforth, MD, vice
chairman and chancellor emeritus
of Washington University. “I have
“We have the right world- a personal reason to be grateful.
And so do many others.”
leading scientists, with
As science continues to shed
the right vision, and the right
new light on old problems, sometimes one disease, such as cerebral
infrastructure, to mount
palsy, can be seen as part of a family
an attack on these
of diseases — in this case, neurocrippling diseases.” degenerative diseases.
If that group of diseases is
— WILLIAM H. DANFORTH, MD
then studied by a multidisciplinary group of researchers, the
collaborative effort could result in more rapid
scientific breakthroughs focused on prevention
and treatment.
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“It makes sense for more scientists and physicians to come together around common central
facilities and databases for a family of diseases
rather than a single disease,” says Danforth.
“They can draw more effectively from diverse
fields such as genetics and immunology.”
Washington University School of Medicine is
leading a collaborative effort to prevent, diagnose
and treat a wide range of neurodegenerative
diseases. The Hope Center for Neurological
Disorders was established in 2004. The center
brings together more than 500 world-class
scientists in a collaborative environment with
the goal of rapidly translating basic scientific
discoveries into direct patient care.
The School of Medicine needs your help to
escalate research into neurological disorders.
A generous gift of $10 million from the Danforth
Foundation is leading the way and encouraging
others to consider important endowment commitments to support research at the Hope Center.
“The Hope Center puts together the right
world-leading scientists, with the right vision,
and the right infrastructure, to mount an attack
on these crippling diseases,” says Danforth.
“The challenge for us all is to join the Hope
Center in the pursuit of this noble cause.”
Spring 2013
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Understanding the brain is a critical frontier in
modern medicine. Please consider funding this or
other opportunities to advance human health.
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Genetic research support for neuromuscular diseases
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classnotes
1940 S
Robert Gibb, MD 48
Gibb has served as president of the
Western Pathologists Quality Assurance
Association. He has been involved in the
establishment of 11 scholarship endowments for schools of medical technology
or clinical laboratory scientists at 10
universities and technical institutions.
Roger Fox, MD 49
Fox and his wife are enjoying life about
one mile from the Pacific Ocean. They
have four children, eight grandchildren,
and eight great grandchildren; still enjoy
traveling; and have been on all seven
continents and to 44 countries so far.

provost for health sciences at George
Washington University. She enjoys traveling to San Francisco to visit her son, a pediatric anesthesiologist, and grandchildren.
Seth Eisen, MD 66
Eisen has been serving as national
director of the Veterans Administration’s
Health Services Research and Development program in Washington DC. He and
his wife, Marion, love the extensive system
of bicycle trails available in the area and
the rich American history of the city.
Chuck Robertson, MD 66
Robertson and his wife, Dianne
Robertson, LA 64, celebrated their 50th
anniversary with a Mediterranean cruise.
They enjoyed having their children and
grandchildren join them on the cruise.

1950 S

1970 S

Robert Hermann, MD 54
Hermann is enjoying retirement, still
playing some golf and tennis, and
traveling with his wife, Polly.

Mark Edelstein, MD 75, GR 75
Edelstein retired from the Veterans Administration (VA) in 2011 after working at the
Detroit VA Medical Center for 27 years.

David Perkins, MD 55
Perkins and his wife, Marge (Hollan),
LA 51, were honored recently by the
Saint Louis Zoo with the individual
Zoo Award. They also were featured in a
recent Playbill at the St. Louis Symphony
for their philanthropic support.

Linda Hershey, MD 75
Hershey directs a dementia clinic at
Oklahoma University Medical Center and
tests new therapies for Alzheimer’s disease.

Robert C. Meredith, MD 57
Meredith retired from the practice of
medicine as a board-certified neurosurgeon in July 2010. He and his wife,
Joanne (Schwam) Meredith, NU 56,
have been married for more than 55 years.
The couple enjoys traveling and spending
time with their children and grandchildren.

1960 S
Donald Stewart Jr., MD 61
Stewart and his wife, Anne, have four
children and 10 grandchildren. He still
enjoys doing some oil painting.
Carolyn Robinowitz, MD 64
Robinowitz recently completed her tenure
as editor-in-chief of Psychiatric News
and currently serves as special associate
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David Magarik, MD 76
Magarik is soon to become a “grandpa”
to twins and a father-in-law for the third
time. He encourages fellow alumni to stay
curious and look for “the most interesting
case” and welcomes visitors to stop by and
visit when in the Shenandoah Valley.

1980 S
Bart Mandelbaum, MD 80
Mandelbaum recently served at the
London 2012 Olympics as medical officer for IOC FIFA for the fourth time. He
was also recently appointed director of
research for Major League Baseball.
Steven Perlmutter, MD 80
Perlmutter received his JD magna cum
laude in 2011. His work concentrates on
representing health care professionals in
front of their respective licensing boards.

Bob Mittle, MD 85
Mittle is president of Charlotte Radiology,
one of the largest private diagnostic radiology groups in the country, and lives in
Charlotte with his family. His four children
are very accomplished, including one son
in his first year of medical school.

1990 S
Ron Pearson, MD 90
Pearson is serving as the state survey
agency director for the State of Wyoming.
Jennifer Scheer, MD 94
Scheer is working as a family doctor in
rural Missouri and is enjoying new
responsibilities in an administrative role
as a physician leader.
Mark Cohen, EN 94, MD 98, HS
Cohen is associate professor and vice chair
of surgery at the University of Kansas
Medical Center and also recently founded
a biotech company (NanoPheum), which
makes safer, more effective chemotherapy
drugs. He lives in Kansas City with his wife
and two children.
Jolie Holschen, LA 95, MD 99
Holschen has accepted a new position
in private practice emergency medicine
with Infinity Healthcare in Chicago IL.
She serves on the Sports Medicine Board
Exam Committee for the American
Board of Emergency Medicine.

2000 S
Emily Engelland, MD 01
Engelland is practicing occupational
medicine and working as the managing
physician at U.S. HealthWorks Medical
Group in Robbinsdale MN. She is engaged
to be married in May 2013.
Jonathan Chung, MD 04
Chung was elected to the editorial board
of the Journal of Thoracic Imaging and
joined the American College of Radiology
Appropriateness Criteria Panel: Thoracic.
Kevin Wilson, MD 05
Wilson is an assistant professor of otolaryngology at the University of Utah in Salt
Lake City and has four children who keep
him and his wife, Emily, busy.
Spring 2013

In Memory
Leo Sachar, MD 40
Sachar died on Dec. 9, 2010. He was chief
of surgery and president of the medical staff at Jewish Hospital after serving
as a U.S. Army surgeon during WWII. He
enjoyed teaching medical students and
training surgeons. Later he was vice chairman of the board and vice president for
medical affairs at St. Elizabeth’s Hospital
in Belleville IL.

Harry Lichtwardt, MD 43
Lichtwardt died on Nov. 22, 2012, at age
93. During WWII he served as head of
the medical corps on Okinawa. He later
practiced medicine in Detroit and helped
develop a urological practice pioneering
many developments in urologic equipment and procedures. He served as president and historian at the North-Central
Section of American Urological Associates.
Pauline Stokes, NU 44
Stokes died on Aug. 28, 2012, at age 89.
She was a registered nurse at Fayette
County Hospital for many years.
Donald W. Bussmann, MD 45
Bussmann died on Jan. 17, 2011. He was
90. After completing medical school,
he served as a medical officer in the U.S.
Army. Later in his career, he helped to
found the Department of Cardiology
and served as director of the Cardiac
Auscultation Lab and associate professor of
internal medicine at Saint Louis University.
Lawrence O’Neal, MD 46
O’Neal died on July 29, 2012, at age 89.
After completing his medical degree
during an accelerated wartime program,
he trained in surgery at Barnes Hospital
where he then remained on staff. He contributed to medical literature as author,
editor and reviewer and also engaged in
clinical research on endocrine subjects.
He co-edited a volume on diabetic foot
problems in 1973 that has gone into
seven editions and been published in
several languages. For eight years he

was chairman of the Department of
Surgery at St. John’s Medical Center and
also helped develop a program for surgical training between the hospital and
Saint Louis University. After retirement,
outlook.wustl.edu

he was medical director of the Sisters of
Mercy Health System. O’Neal received the
Alumni Achievement Award in 1991 from
Washington University. He enjoyed writing
and photography.
Robert J. Glaser, HS 47
Glaser died June 7, 2012, at age 93. Before
completing residency at Barnes Hospital,
he attended Harvard Medical School. At
Washington University, he served as an
associate professor, assistant dean and
associate dean before moving to serve
at the University of Colorado and then
Stanford School of Medicine, where he
acted as dean and vice president for medical affairs in both posts. He received many
awards and honors during his career and
was active nationally in medical
education.
Janet S. Gilman, MD 49
Gilman died on Jan. 17, 2011 at 86. She
practiced at Sharp Chula Vista Hospital for
more than 30 years, many as chief of anesthesia and chief of staff. She is remembered as a pioneer of women practicing
medicine. She was well respected professionally and liked personally by those with
whom she worked. She loved pets and
always had dogs or cats. She is survived by
her three children and grandchildren.
Melvin Lee Faw, MD 51
Faw died on April 16, 2012. After earning
two Purple Hearts and three Bronze Stars
during WWII, he completed his undergraduate studies. After receiving his medical degree from Washington University,
he completed an internship and residencies in internal medicine and cardiology
at Washington University and Kansas
University. He practiced internal medicine
at Welborn Clinic in Evansville IN from
1955–87, where he was managing partner.
He is survived by children, grandchildren
and great-grandchildren.
Jeanne McDonald, NU 54
McDonald died on April 19, 2012. During
her career she worked at Boone Hospital
and University Hospital and for the
Department of Health. She was an active
member of the Ashland Garden Club
and enjoyed singing in the church choir.
Survivors include children, grandchildren
and great-grandchildren.

Faculty
Helen E. Nash, MD
Nash, professor emerita (clinical) in pediatrics, died on Oct. 4, 2012. She was 91. In
1949, she was the first African-American
physician to join the attending staff at
St. Louis Children’s Hospital and the first
African-American woman to join the faculty of Washington University School of
Medicine. She served at both institutions
for more than 40 years. At the same time,
she maintained a thriving private practice
at Grand Boulevard and Cass Avenue in
the African-American business district. In
1993, Nash retired from medical practice
and soon began serving as the medical
school’s dean of minority affairs. During
her tenure, she was credited with raising
the academic achievements of minority
students. Earlier in her career, she also
served as pediatric supervisor and associate director of pediatrics at Homer G.
Phillips Hospital and as president of the
St. Louis Children’s Hospital attending
staff. The medical school recognized her
lifetime contributions by creating the
Dr. Helen E. Nash Academic Achievement
Award. Nash was heralded by physicians
throughout St. Louis for her commitment
to excellence, tireless advocacy on behalf
of children, and endless enthusiasm for
the field of medicine.

Alfred I. Sherman, MD 55
Sherman died on Aug. 25, 2012. He was
91. After training in urology and pathology, he followed his mentor, Willard Allen,
MD, to Washington University and Barnes
Hospital in St. Louis, staying 20 years. He
later served on the faculty at Wayne State
University School of Medicine and as head
of the obstetrics/gynecology department
at Sinai Hospital in Detroit MI. After
retiring from Sinai in 1975, he went into
private practice and continued teaching,
lecturing and writing until he “officially”
retired at the age of 85.

If you wish to make a tribute gift in honor
of any of the above alumni or faculty,
please contact: Pamela Buell, Washington
University Medical Alumni and Development,
Campus Box 1247, 7425 Forsyth Blvd., Suite 2100,
St. Louis MO 63105-2161, (314) 935-9691.
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advancing health

Together
transforming lives
Leading together, the Washington University
community defines the forefront of medical innovation
— advancing human health, preparing tomorrow’s
leaders, and enriching the quality of life. A simple yet
significant way to support these efforts is by making
a planned gift through your will, trust, life insurance,
IRA, or qualified retirement plan.

Benefits can include:
n

Supporting scholarships, professorships, research,
and programs that are important to you

n

Reducing estate taxes

n

Retaining control of assets during your lifetime

To learn how you can make a planned gift,
contact the Office of Planned Giving:

(800) 835-3503 or (314) 935-5373
Poster session in the Farrell Learning and Teaching Center.

plannedgiving.wustl.edu

Together, we can change lives!
For information on supporting the School of Medicine
through an outright gift, contact:
Pamela Buell, Associate Vice Chancellor for
Medical Alumni and Development
(314) 935-9691

email: meddev@wustl.edu
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Consult with your legal or tax advisor before making a charitable gift.
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The wonder of it all
This early 17th century book illustration
of the cosmos integrated ancient
mystical beliefs with contemporary
scientific concepts. Its author, Oxford
physician Robert Fludd, advocated for
alchemy as the basis of new medicine,
whereas Johannes Kepler regarded math
as the only proper basis for natural
science; a publishing battle ensued.
A recent exhibit in the Bernard Becker
Medical Library, Occultism and Science in
the Early Modern World, displayed several
other examples from this transitional era
in the history of science, when natural
and supernatural were understood along
a continuum. However, observation —
and calculation — later became the
prime mechanisms of scientific progress.

Washington University School of Medicine
Office of Medical Public Affairs
Campus Box 8508
4444 Forest Park Ave.
St. Louis, MO 63108
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